OptimizeRx to Present at ROTH Technology Corporate Access Day on November 14, 2018
25 Oktober 2018 - 5:52PM
OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital
health messaging for the pharmaceutical industry, has been invited
to participate in the 4th Annual ROTH Technology Corporate Access
Day being hosted by ROTH Capital Partners on November 14, 2018 at
the Empire Steak House in New York City.
This event will provide investors the opportunity to meet with
senior management in a one-on-one and small group format.
OptimizeRx CEO William Febbo will discuss a number of topics,
including the company’s results for the third quarter of 2018,
recent acquisition of CareSpeak Communications, and the growth of
the company’s digital health network. The network is the largest of
its kind, reaching more than half of the ambulatory patient market
in the U.S.
For the second quarter of 2018, the company reported its seventh
consecutive quarter of revenue growth, up 78% to a record $5.1
million. Diluted EPS totaled $0.02, with a gross margin improving
from 44.0% to 56.1%.
Medication adherence improves when patients can identify ways of
lowering their co-payments, according to industry
research. OptimizeRx addresses the challenges adherence and
rising drug costs by delivering copay coupons, savings vouchers and
important clinical messaging at the point of care.
The event is by invitation only for institutional clients of
ROTH Capital Partners. To schedule a meeting with OptimizeRx,
please contact your ROTH sales representative at (800) 933-6830
or conference@roth.com.
For more information about OptimizeRx, contact Ron Both of CMA
at (949) 432-7557 or submit your request here.
About ROTH Capital Partners ROTH Capital
Partners, LLC is a relationship-driven investment bank focused on
serving emerging growth companies and their investors. As a
full-service investment bank, ROTH provides capital raising,
M&A advisory, analytical research, trading, market-making
services and corporate access. Headquartered in Newport Beach, CA,
ROTH is privately-held and employee owned, and maintains offices
throughout the U.S. For more information on ROTH, please
visit www.roth.com.
About OptimizeRx OptimizeRx® (NASDAQ: OPRX) is
one of the nation’s leading providers of digital health messaging
via electronic health records (EHRs), providing a direct channel
for pharma companies to communicate with healthcare providers. The
company’s cloud-based solution supports patient adherence to
medications by providing real-time access to financial assistance,
prior authorization, education, and critical clinical information.
The company’s network is comprised of leading EHR platforms like
Allscripts, Amazing Charts and Quest, and provides more than half
of the ambulatory patient market with access to these benefits
within their workflow at the point-of-care. For more information,
follow the company on Twitter, LinkedIn or
visit www.optimizerx.com.
Important Cautions Regarding Forward Looking
Statements This press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition and other material risks.
OptimizeRx ContactDoug Baker, CFOTel (248)
651-6568 x807dbaker@optimizerx.com
Media Relations ContactNicole Brooks, Innsena
Communications(Tel) 860-800-2344nicolebrooks@innsena.com
Investor Relations ContactRon Both, CMATel
(949) 432-7557oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024